This announcement is a separate document:
坪田ラボ：「パーキンソン病」を対象としたTLG-005の特定臨床研究結果の速報について
Tsubota Laboratory: Announcement of preliminary results of specific clinical study of TLG-005 targeting Parkinson's disease.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.